GemPharmatech and Humlab Global Sign Strategic Agreement to Deliver Humanized Mouse Models for Improved Clinical Translation

SINGAPORE & SAN DIEGO--(BUSINESS WIRE)--GemPharmatech, an international provider of in vivo efficacy testing and genetically engineered animal models, and Humlab Global, a Singapore-based developer of humanized mouse models and translational research solutions, today announced the signing of an agreement for the global distribution of existing and novel humanized strains. The rapid development of advanced therapeutics has increased the need for in vivo models that better predict drug efficacy a

SINGAPORE & SAN DIEGO--(BUSINESS WIRE)--GemPharmatech, an international provider of in vivo efficacy testing and genetically engineered animal models, and Humlab Global, a Singapore-based developer of humanized mouse models and translational research solutions, today announced the signing of an agreement for the global distribution of existing and novel humanized strains. The rapid development of advanced therapeutics has increased the need for in vivo models that better predict drug efficacy a